<p>Comparison of the effectiveness<sup>a</sup> of the monovalent XBB.1.5 COVID-19 vaccines against XBB and BA.2.86 VSLs among hospitalised SARI patients aged ≥65 years, by TSV, using the adapted predominance period (PP) with VSL category model (VCM) and with VSL proportion model (VPM) approaches, VEBIS hospital network, Europe.</p>
收藏NIAID Data Ecosystem2026-05-10 收录
数据链接：
官方服务：
资源简介：
Comparison of the effectivenessa of the monovalent XBB.1.5 COVID-19 vaccines against XBB and BA.2.86 VSLs among hospitalised SARI patients aged ≥65 years, by TSV, using the adapted predominance period (PP) with VSL category model (VCM) and with VSL proportion model (VPM) approaches, VEBIS hospital network, Europe.
创建时间：
2026-03-09
